Industry-Driven Degree Program Launches this Fall to Fill a Gap in Biotech Workforce

Published on :

Industry-Driven Degree Program Launches this Fall to Fill Gap in Biotech Workforce In this exciting age of science, technology, and innovation, more and more high schoolers, college students, and graduate students are becoming interested in pursuing a career in biotech.  But, is the standard science degree (i.e. Biology, Chemistry, and Physics) keeping up with this [….]

Aaron Chang, Renalert CEO – Engineering a Global Paradigm Shift to Prevent Acute Kidney Injury

Published on :

In Conversation with Aaron Chang, CEO of Renalert – Engineering a Global Paradigm Shift to Prevent Acute Kidney Injury Every entrepreneur has a “founder’s story” that serves to build the unique framework for why they are just the right person to solve a specific problem. For Aaron Chang, CEO of Renalert, that story began at Johns [….]

From Turnaround CEO to Early Stage HealthTech Investor, A Fireside Chat with the Director of the INOVA Personalized Health Accelerator

Published on :

From Turnaround CEO to Early Stage HealthTech Investor, A Fireside Chat with the Director of the INOVA Personalized Health Accelerator Can a Successful Turnaround CEO help Turnaround the early stage HealthTech investment market? That’s a question that was partially answered on Monday when Startup Grind Columbia hosted Mike Thomas, Director of the INOVA Personalized Health [….]

What Can You Learn from 5 Successful Women in Pharma?

Published on :

A Women’s Leadership Panel Discussion & Dinner In my humble opinion after meeting the women below, the more appropriate question is; What Can’t you learn from 5 successful Women in Pharma? ISPE’s Women In Pharma (WIP) group is a relatively new community within ISPE that is quickly growing in membership and spreading into new chapters. [….]

This UMD Program is Solving Critical Challenges for both Startups & Commercial Biotechs

Published on :

Get to know The Biotech Research & Education Program Three of the top challenges that most start-up biotech companies experience are a lack of (1) the laboratory and equipment resources, (2) the skilled manpower and (3) the money that they need to scale their technology. Without these three components good technology will either sit on the shelf awaiting the needed funding [….]

George Davis, CEO of TEDCO

Published on :

Welcome to the latest installment of In Conversation, a BioHive conversation series with innovators and thought leaders in the BioHealth Capital Region. Joining us today is George Davis, the up and coming CEO of TEDCO. George is bringing a wealth of experience and knowledge about the startup field to TEDCO and we’re excited to share his [….]

Unknown Future for Frederick Vaccine Company After Recent Acquisition by General Dynamics

Published on :

Among the giant Federal Government defense contractors that line the DC beltway there is a small business unit within CSRA that resides out in Frederick, MD. As the sole life science business within the larger conglomerate, DynPort Vaccine Company (DVC) manages vaccine product develop for Federal biodefense and other related public health programs.  Founded in 2003, DVC was one of the first biodefense players in the market and now [….]

In Conversation with Deborah Hemingway, PhD Candidate and Entrepreneur

Published on :

Welcome back to In Conversation, a series of conversations with thought leaders and disruptors in the BioHealth Capital Region. This week we’re talking with an up-and-coming mover and shaker, Deborah Hemingway, PhD candidate at the University of Maryland, College Park. Graduating this December with a degree in biophysics and landing a job as a CEO for a [….]

Top 10 U.S. Biopharma Clusters

Top 10 BioPharma Clusters
Published on :

Bruce Booth, D.Phil., a partner at Atlas Venture, astutely observed earlier this year that two key resources fueling the growth of biopharma were until recently somewhat geographically spread among the 10 or so regions of the nation where the industry began to arise a generation ago. “In recent years, this has changed—Boston and San Francisco [….]